Cardinal Health, Inc. (NYSE:CAH) Shares Acquired by Buckley Wealth Management LLC

Buckley Wealth Management LLC increased its stake in Cardinal Health, Inc. (NYSE:CAH) by 3.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,392 shares of the company’s stock after acquiring an additional 405 shares during the period. Buckley Wealth Management LLC’s holdings in Cardinal Health were worth $1,259,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CAH. Tobam boosted its stake in shares of Cardinal Health by 773.4% in the 1st quarter. Tobam now owns 49,111 shares of the company’s stock valued at $5,496,000 after buying an additional 43,488 shares during the period. Mitsubishi UFJ Trust & Banking Corp grew its holdings in Cardinal Health by 101.1% during the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 321,558 shares of the company’s stock worth $36,010,000 after acquiring an additional 161,656 shares in the last quarter. State Board of Administration of Florida Retirement System increased its position in shares of Cardinal Health by 5.2% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 314,213 shares of the company’s stock valued at $35,160,000 after purchasing an additional 15,663 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its holdings in shares of Cardinal Health by 1.7% in the 1st quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 393,350 shares of the company’s stock valued at $44,016,000 after purchasing an additional 6,752 shares in the last quarter. Finally, Alpha Cubed Investments LLC purchased a new stake in shares of Cardinal Health during the 3rd quarter worth $371,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

Shares of NYSE:CAH traded up $0.48 on Friday, reaching $112.41. The company’s stock had a trading volume of 1,369,588 shares, compared to its average volume of 2,086,768. Cardinal Health, Inc. has a 52-week low of $90.19 and a 52-week high of $116.05. The stock has a market capitalization of $27.38 billion, a P/E ratio of 49.96, a PEG ratio of 1.57 and a beta of 0.60. The stock’s 50-day moving average is $111.00 and its two-hundred day moving average is $103.96.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Wednesday, August 14th. The company reported $1.84 EPS for the quarter, beating the consensus estimate of $1.74 by $0.10. Cardinal Health had a negative return on equity of 54.85% and a net margin of 0.37%. The firm had revenue of $59.87 billion during the quarter, compared to the consensus estimate of $58.74 billion. During the same period in the prior year, the business earned $1.55 EPS. The firm’s revenue was up 12.1% compared to the same quarter last year. Equities analysts forecast that Cardinal Health, Inc. will post 7.61 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st were given a $0.506 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.80%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date was Tuesday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is 89.78%.

Insider Buying and Selling at Cardinal Health

In other news, CEO Jason M. Hollar sold 26,716 shares of Cardinal Health stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $108.87, for a total value of $2,908,570.92. Following the sale, the chief executive officer now owns 244,091 shares of the company’s stock, valued at $26,574,187.17. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO Jason M. Hollar sold 26,716 shares of Cardinal Health stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $108.87, for a total value of $2,908,570.92. Following the sale, the chief executive officer now directly owns 244,091 shares in the company, valued at $26,574,187.17. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Jessica L. Mayer sold 17,896 shares of the stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $106.48, for a total value of $1,905,566.08. Following the completion of the transaction, the insider now owns 94,529 shares of the company’s stock, valued at $10,065,447.92. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 113,963 shares of company stock valued at $12,379,980. 0.15% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on CAH shares. JPMorgan Chase & Co. raised their price target on Cardinal Health from $111.00 to $123.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. StockNews.com upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Thursday. Robert W. Baird raised their price objective on shares of Cardinal Health from $130.00 to $137.00 and gave the stock an “outperform” rating in a report on Thursday, August 15th. Evercore ISI upped their target price on shares of Cardinal Health from $105.00 to $115.00 and gave the company an “in-line” rating in a report on Thursday, August 15th. Finally, Wells Fargo & Company increased their target price on shares of Cardinal Health from $95.00 to $101.00 and gave the company an “underweight” rating in a research report on Thursday, August 15th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $119.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.